NGS Market 2017 Forecasts and Latin American Next-Generation Sequencing Research Reports
DALLAS, April 27, 2014 /PRNewswire/ –
ReportsnReports.com offers Next-Generation Sequencing in Latin America market research
report by Kalorama Information and Next Generation Sequencing (NGS) Market [Platforms
(Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics
(RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] -
Global Forecast to 2017 research report by MarketsandMarkets in its store.
The next generation sequencing market is rapidly evolving with a large number of
developments taking place to increase accuracy and speed, and reduce costs of sequencing.
It is the fastest-growing and most lucrative segment in the genomics space with an
estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is
poised to reach $2.7 billion by 2017. By supporting genomics research, various government
bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and
Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of
high-throughput sequencing platforms. Read more in the report Next Generation Sequencing
(NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454
Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics,
Personalized Medicine)] – Global Forecast to 2017 available at
Next Generation Sequencing in Latin America market research report by Kalorama
) is a look at the use of DNA sequencing systems in the region, based on Survey
conducted by VA Consultadoros in Fall 2013. The survey focused on instrumentation, with a
goal of providing a complete count of NGS systems sold to customers in key Latin American
Genomics studies product cycle with Next Generation Sequencing (NGS) technology in
Latin America (LatAm) is in its exponential phase and market growth is larger than the
regional investment in Science and Technology (S&T) compared against the expenditure in
S&T as a percentage of GDP. Because of that is necessary to know more details about the
market dynamics, products/applications segmentation and main purchase drivers.
As part of its coverage, this report contains the following data:
Number of Next Generation Sequencing Systems Installed by Country
- - Brazil - - Mexico - - Argentina - - Chile - - Columbia - - Others
Brands of Next Generation Sequencing Systems Installed In Latin America, Cross-
Referenced By Country
- - Roche - - Illumina - - Life - - Others
Economic Statistics for Latin American Countries
Scientific and Technical Spending for Latin American Countries
Next Generation Sequencing Systems by Throughput Category
The survey was performed interviewing Distributors with local or regional presence,
opinion leaders, manufacturers of systems and reagents for the Life Sciences market
segment, research institutes and tender’s calls. Twenty two interviews were performed that
let gather information about eight countries (Argentina, Brazil, Chile, Colombia, Mexico,
Panama, Peru and Uruguay) along the period June/September 2013.
This market survey and analysis shows information about geographical distribution, lab
category distribution, manufacturer’s analysis, instruments distribution by throughput
category and market trends for the coming years. As part of its coverage, applications
were not in the scope of this report.
The report is collaboration between Kalorama Information and VA Consultora y
Asociados. VA Consultora y Asociados is a consultant company founded and directed by Dr.
Maria Victoria Allais, with more than 20 years in the IVD market and its different
segments. Internal knowledge and expertise lead to real time intelligence on the
diagnostic market including new technologies and forecasting. In-depth qualitative and
quantitative research focused on LATAM region and country specific trends. Order a copy of
this report at http://www.reportsnreports.com/Purchase.aspx?name=277071 .
The Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life
Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq),
(Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to
2017 research report says next generation sequencing is set to revolutionize applied
markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, and
agriculture and animals research. Research institutes and government bodies contribute the
highest to the end-user market of NGS; however, the adoption rate in hospitals will
increase in the near future due to cost effectiveness, high throughput, and sensitivity.
The NGS market will witness a whole new generation of sequencing platforms based on
nanapore sequencing technology and fully integrated instruments that could perform all the
NGS workflow steps.
Companies profiled in this NGS market report include 454 Life Sciences Corporation (A
Roche Company), Agilent Technologies, Inc., BGI (Beijing Genomics Institute), Biomatters,
Ltd., CLC Bio, Dnastar, Inc., EMC Corporation, GATC biotech AG, Genomatix Software GMBH,
Illumina, Inc., Knome, Inc., Life Technologies Corporation, Macrogen, Inc., Ocimum
Biosolutions, Ltd., Oxford Nanorpore Technologies, Ltd., Pacific Biosciences, Partek
Incorporated, Perkinelmer, Inc., Qiagen N.V. and Strand Life Sciences Pvt. Ltd. Order a
copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=257153 .
Global Next Generation Sequencing Market 2012-2016 report
has been prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the market in the Americas, and the EMEA and APAC
regions; it also covers the Global Next Generation Sequencing market landscape and its
growth prospects in the coming years. The report also includes a discussion of the key
vendors operating in this market. The key vendors dominating this market space are
Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of
California Inc. The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics
Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp.,
Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc.,
NABsys Inc., Oxford Nanopore Technologies Ltd., Pathogenica Inc., QIAGEN N.V, RainDance
Technologies Inc., Sequenom Inc., Takara Bio Inc. Order a copy of this report at
Explore more reports on the biotechnology market at
ReportsnReports.com is an online market research reports library
[http://www.reportsnreports.com ] of 400,000+ in-depth studies of over 5000 micro markets.
Our database includes reports by leading publishers from across the globe. We provide 24/7
online and offline support service to our customers.
TX, Dallas North – Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Connect With Us on: